THE IBN SINA PHARMACEUTICAL INDUSTRY PLC revenue for the last year amounted to 9.12 B BDT, the most of which — 3.25 B BDT — came from its highest performing source at the moment, Tablet, the year earlier bringing 3.21 B BDT. The greatest contribution to the revenue figure was made by Bangladesh — last year it brought THE IBN SINA PHARMACEUTICAL INDUSTRY PLC 9.13 B BDT, and the year before that — 8.48 B BDT.